Modified DNA aptamers
Chemically synthesized substances in which amino acid side chains are deployed on one end of a strand of natural DNA to increase their affinity for particular biological molecules, giving them properties that are similar or superior to antibodies.
 Grant from New Energy and Industrial Technology Development Organization (NEDO) of Japan
Part of the Project for Developing Biotechnology IT Integration Equipment, which ran from fiscal 2002 to fiscal 2005
Fujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 170,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 4.4 trillion yen (US$47 billion) for the fiscal year ended March 31, 2013. For more information, please see http://www.fujitsu.com.
All other company or product names mentioned herein are trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and is subject to change without advance notice.
Date: 15 August, 2013
Company: Fujitsu Limited, , , , , , , , , , , , ,
Share this page